Evoke Pharma Company Profile (NASDAQ:EVOK)

About Evoke Pharma

Evoke Pharma logoEvoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. EVK-001 is a formulation of Metoclopramide drug, designed to provide systemic delivery of metoclopramide through intranasal administration. The Company has evaluated EVK-001 in a multicenter, randomized, double-blind, placebo-controlled parallel group, dose-ranging Phase IIb clinical trial. The Company has commenced a Phase III clinical trial of EVK-001 in female patients with symptoms associated with acute and recurrent diabetic gastroparesis. The Phase III clinical trial is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy, safety and population pharmacokinetics of EVK-001 in adult females.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: EVOK
  • CUSIP:
Key Metrics:
  • Previous Close: $2.02
  • 50 Day Moving Average: $2.07
  • 200 Day Moving Average: $4.43
  • 52-Week Range: $12,350,000.00 - $1.52
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.35
  • P/E Growth: -0.04
  • Market Cap: $24.95M
  • Outstanding Shares: 12,350,000
  • Beta: 0.72
Profitability:
  • Return on Equity: -578.42%
  • Return on Assets: -141.29%
Debt:
  • Current Ratio: 0.75%
  • Quick Ratio: 0.75%
Additional Links:
Companies Related to Evoke Pharma:

Analyst Ratings

Consensus Ratings for Evoke Pharma (NASDAQ:EVOK) (?)
Ratings Breakdown: 1 Sell Rating, 5 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.13)
Consensus Price Target: $10.93 (441.02% upside)

Analysts' Ratings History for Evoke Pharma (NASDAQ:EVOK)
Show:
DateFirmActionRatingPrice TargetDetails
8/16/2016HC WainwrightSet Price TargetHold$2.50View Rating Details
8/16/2016FBR & CoReiterated RatingOutperform$9.00View Rating Details
8/16/2016Noble FinancialReiterated RatingHoldView Rating Details
7/18/2016Northland SecuritiesDowngradeOutperform -> Market PerformView Rating Details
7/18/2016Feltl & Co.DowngradeStrong-Buy -> SellView Rating Details
7/18/2016Rodman & RenshawDowngradeBuy -> Neutral$2.00View Rating Details
7/18/2016Brean CapitalDowngradeBuy -> HoldView Rating Details
3/14/2016Ascendiant Capital MarketsBoost Price TargetBuy$11.00 -> $12.00View Rating Details
5/15/2015Cantor FitzgeraldReiterated RatingBuy$20.00View Rating Details
12/3/2014MLV & Co.Boost Price TargetBuy$12.50 -> $14.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Evoke Pharma (NASDAQ:EVOK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/15/2016Q216($0.43)($0.41)ViewListenView Earnings Details
5/11/2016Q116($0.41)($0.45)ViewListenView Earnings Details
3/10/2016Q415($0.45)($0.37)ViewListenView Earnings Details
11/12/2015Q315($0.54)($0.42)ViewListenView Earnings Details
8/13/2015Q215($0.60)($0.52)ViewListenView Earnings Details
5/14/2015Q115($0.55)($0.58)ViewListenView Earnings Details
3/4/2015Q414($0.68)($0.48)ViewN/AView Earnings Details
11/13/2014($0.78)($0.63)ViewN/AView Earnings Details
8/13/2014($0.73)($0.59)ViewN/AView Earnings Details
5/13/2014Q114($0.36)($0.49)ViewN/AView Earnings Details
3/25/2014Q413($0.16)($0.27)ViewN/AView Earnings Details
11/13/2013Q3 13($0.10)($0.41)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Evoke Pharma (NASDAQ:EVOK)
Current Year EPS Consensus Estimate: $-1.19 EPS
Next Year EPS Consensus Estimate: $-0.86 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.48)($0.37)($0.43)
Q2 20162($0.47)($0.47)($0.47)
Q3 20162($0.42)($0.29)($0.36)
Q4 20162($0.41)($0.22)($0.32)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Evoke Pharma (NASDAQ:EVOK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Evoke Pharma (NASDAQ:EVOK)
Insider Ownership Percentage: 30.50%
Institutional Ownership Percentage: 8.19%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2016Parters Vii L P DomainMajor ShareholderSell344,120$4.70$1,617,364.00View SEC Filing  
4/27/2016Parters Vii L P DomainMajor ShareholderSell5,095$5.07$25,831.65View SEC Filing  
4/25/2016Parters Vii L P DomainMajor ShareholderSell1,492$5.20$7,758.40View SEC Filing  
4/20/2016Parters Vii L P DomainMajor ShareholderSell41,478$5.35$221,907.30View SEC Filing  
4/11/2016Parters Vii L P DomainMajor ShareholderSell4,348$5.22$22,696.56View SEC Filing  
4/8/2016Parters Vii L P DomainMajor ShareholderSell51,004$5.28$269,301.12View SEC Filing  
8/18/2015Parters Vii L P DomainMajor ShareholderSell11,836$7.02$83,088.72View SEC Filing  
4/16/2015Parters Vii L P DomainMajor ShareholderSell50,163$7.29$365,688.27View SEC Filing  
9/23/2014Todd C BradyDirectorBuy4,000$5.70$22,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Evoke Pharma (NASDAQ:EVOK)
DateHeadline
investornewswire.com logoShares Of Evoke Pharma, Inc. (NASDAQ:EVOK) Expected To Hit $9 - Investor Newswire (NASDAQ:EVOK)
www.investornewswire.com - September 25 at 4:28 PM
News IconUnder the Microscope, Zeroing in at Evoke Pharma, Inc. (NASDAQ:EVOK) - Duncan Research (NASDAQ:EVOK)
www.duncanindependent.com - September 23 at 4:41 PM
News IconKeen Investors Find News on Evoke Pharma, Inc. (NASDAQ:EVOK) - Duncan Research (NASDAQ:EVOK)
www.duncanindependent.com - September 23 at 4:41 PM
News IconStock Update on Earnings & Estimates for Evoke Pharma, Inc ... - Frisco Fastball (NASDAQ:EVOK)
friscofastball.com - September 21 at 5:27 PM
News IconSell-side Consensus Sees Evoke Pharma, Inc. (NASDAQ:EVOK) Going Where Near-Term? - Frisco Fastball (NASDAQ:EVOK)
friscofastball.com - September 21 at 5:27 PM
News IconEvoke Pharma Incorporated (NASDAQ:EVOK) Shorted Shares Increased By 35.68% - Post News (NASDAQ:EVOK)
www.kentuckypostnews.com - September 19 at 3:50 PM
News IconGlobal gastrointestinal diseases market grows at a steady CAGR with strong rise in demand explored in latest research (NASDAQ:EVOK)
www.whatech.com - September 19 at 9:35 AM
247wallst.com logo4 Key BioPharma Movers in the Past Week (NASDAQ:EVOK)
247wallst.com - September 19 at 9:35 AM
bizjournals.com logoHow These Generic Drugs Stocks are Faring? -- Evoke Pharma, Mallinckrodt, Catalyst Pharma, and Momenta Pharma (NASDAQ:EVOK)
www.bizjournals.com - September 16 at 4:50 PM
prnewswire.com logoHow These Generic Drugs Stocks are Faring? -- Evoke Pharma, Mallinckrodt, Catalyst Pharma, and Momenta Pharma - PR Newswire (press release) (NASDAQ:EVOK)
www.prnewswire.com - September 15 at 5:18 PM
News IconShares in Focus: Evoke Pharma, Inc. (NASDAQ:EVOK) Earnings & Targets Update - Frisco Fastball (NASDAQ:EVOK)
friscofastball.com - September 15 at 5:31 AM
News IconEvoke Pharma Inc (NASDAQ:EVOK) Is A Step Closer To A Dramatic Upside Revaluation (NASDAQ:EVOK)
streetregister.com - September 9 at 4:47 PM
News IconHealthcare Top Gainers- Cogentix Medical, Inc. (NASDAQ:CGNT), Evoke Pharma (NASDAQ:EVOK) - Seneca Globe (NASDAQ:EVOK)
www.senecaglobe.com - September 9 at 9:44 AM
News IconEvoke Pharma Inc (NASDAQ:EVOK) Is A Step Closer To A Dramatic Upside Revaluation - Street Register (NASDAQ:EVOK)
streetregister.com - September 9 at 9:44 AM
nasdaq.com logoEvoke Pharma Announces Positive Non-Clinical Pre-NDA Meeting with FDA for Gimoti (NASDAQ:EVOK)
www.nasdaq.com - September 8 at 8:49 AM
News IconStock Showing Gains in Today's Session: Evoke Pharma, Inc. (NASDAQ:EVOK) - Post News (NASDAQ:EVOK)
www.kentuckypostnews.com - September 7 at 5:05 PM
globenewswire.com logoEvoke Pharma Announces Positive Non-Clinical Pre-NDA Meeting with FDA for Gimoti - GlobeNewswire (press release) (NASDAQ:EVOK)
globenewswire.com - September 7 at 5:05 PM
biz.yahoo.com logoEVOKE PHARMA INC Files SEC form 8-K, Other Events (NASDAQ:EVOK)
biz.yahoo.com - September 7 at 5:05 PM
247wallst.com logoIs the FDA Changing Its Tune on Evoke Pharma? (NASDAQ:EVOK)
247wallst.com - September 7 at 5:05 PM
globenewswire.com logoEvoke Pharma to Present at Rodman & Renshaw 18th Annual Global Investment Conference - GlobeNewswire (press release) (NASDAQ:EVOK)
globenewswire.com - September 7 at 8:15 AM
finance.yahoo.com logoEvoke Pharma to Present at Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:EVOK)
finance.yahoo.com - September 6 at 4:49 PM
News IconStock in Review: Taking a Closer Look at Evoke Pharma, Inc. (NASDAQ:EVOK) Shares - Post News (NASDAQ:EVOK)
www.kentuckypostnews.com - August 31 at 9:42 AM
finance.yahoo.com logoEVOKE PHARMA INC Financials (NASDAQ:EVOK)
finance.yahoo.com - August 24 at 4:50 PM
News IconWhat went wrong with evoke pharma inc (nasdaq_evok)_ – market exclusive database javascript (NASDAQ:EVOK)
handyrecovery.in - August 18 at 10:17 PM
News IconWorldwide Diabetic Gastroparesis Marke Segments by 2016-2022 (NASDAQ:EVOK)
www.medgadget.com - August 18 at 4:57 PM
News IconActive Run Stocks Logging Brokers' Choice: Raytheon (NYSE:RTN), Evoke Pharma (NASDAQ:EVOK), Embraer (NYSE ... - Seneca Globe (NASDAQ:EVOK)
www.senecaglobe.com - August 17 at 5:49 AM
News IconHealthcare Stocks Jumps in Fighting Ground- Exact Sciences (NASDAQ:EXAS), Evoke Pharma (NASDAQ:EVOK) - Seneca Globe (NASDAQ:EVOK)
www.senecaglobe.com - August 16 at 4:59 PM
reuters.com logoBRIEF-Evoke Pharma Q2 shr loss $0.41 (NASDAQ:EVOK)
www.reuters.com - August 16 at 8:10 AM
4-traders.com logoEVOKE PHARMA INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) (NASDAQ:EVOK)
www.4-traders.com - August 15 at 5:02 PM
publicnow.com logoEvoke Pharma Reports Second Quarter 2016 Results (NASDAQ:EVOK)
www.publicnow.com - August 15 at 5:02 PM
thestreet.com logoEvoke Pharma (EVOK) Stock Slides in After-Hours Trade Despite Narrower Q2 Loss (NASDAQ:EVOK)
www.thestreet.com - August 15 at 5:02 PM
News IconTracking Earnings for Evoke Pharma Inc (NASDAQ:EVOK) - Post Registrar (NASDAQ:EVOK)
postregistrar.com - August 15 at 12:10 PM
biz.yahoo.com logoQ2 2016 Evoke Pharma Inc Earnings Release - After Market Close (NASDAQ:EVOK)
biz.yahoo.com - August 15 at 12:10 PM
finance.yahoo.com logoEvoke Pharma Schedules Webcast and Conference Call for Second Quarter 2016 Financial Results - Yahoo Finance (NASDAQ:EVOK)
finance.yahoo.com - August 11 at 6:14 AM
publicnow.com logoEvoke Pharma Schedules Webcast and Conference Call for Second Quarter 2016 Financial Results (NASDAQ:EVOK)
www.publicnow.com - August 10 at 12:17 PM
thestreet.com logoEvoke Pharma (EVOK) Stock Drops Ahead of Thursday's Q2 Results (NASDAQ:EVOK)
www.thestreet.com - August 9 at 9:13 PM
fortune.com logoNotable Brokerage Recommendations: Evoke Pharma Inc (NASDAQ:EVOK), Eleven Biotherapeutics Inc (NASDAQ:EBIO) - Review Fortune (NASDAQ:EVOK)
reviewfortune.com - August 9 at 6:15 AM
nasdaq.com logoEvoke Pharma Completes Credit Facility Repayment - Nasdaq (NASDAQ:EVOK)
www.nasdaq.com - August 8 at 5:03 PM
publicnow.com logoEvoke Pharma Completes Credit Facility Repayment (NASDAQ:EVOK)
www.publicnow.com - August 8 at 9:44 AM
biz.yahoo.com logoEVOKE PHARMA INC Files SEC form 8-K, Termination of a Material Definitive Agreement (NASDAQ:EVOK)
biz.yahoo.com - August 8 at 9:44 AM
fortune.com logoNotable Analyst Views: Array Biopharma Inc (NASDAQ:ARRY ... - Review Fortune (NASDAQ:EVOK)
reviewfortune.com - August 6 at 6:38 AM
streetupdates.com logoAnalysts Rating updates about two Stocks: Evoke Pharma, Inc ... - Street Updates (NASDAQ:EVOK)
www.streetupdates.com - August 2 at 5:05 PM
News IconEvoke Pharma Inc (NASDAQ:EVOK) Shares Recover from Drug Trial Slip - Small Cap Exclusive (press release) (NASDAQ:EVOK)
smallcapexclusive.com - August 2 at 5:05 PM
News IconWells Fargo & Co (NYSE:WFC) & Evoke Pharma Inc (NASDAQ:EVOK) Eye-Catching Stocks - Money News (press release) (NASDAQ:EVOK)
www.newsismoney.com - August 2 at 5:05 PM
News IconMeetMe Inc (NASDAQ:MEET): Up On Financials But Should Be Focusing On Users (NASDAQ:EVOK)
streetregister.com - August 2 at 9:45 AM
biz.yahoo.com logoEVOKE PHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securiti (NASDAQ:EVOK)
biz.yahoo.com - August 1 at 8:32 AM
globenewswire.com logoEvoke Pharma Announces $10 Million Registered Direct Offering ... - GlobeNewswire (press release) (NASDAQ:EVOK)
globenewswire.com - July 31 at 4:42 PM
seekingalpha.com logoEvoke Pharma: Hop On And Ride The Elevator Higher - Seeking Alpha (NASDAQ:EVOK)
seekingalpha.com - July 31 at 4:42 PM
streetinsider.com logoEvoke Pharma (EVOK) Enters $10M Registered Direct At-The-Market Stock Offering (NASDAQ:EVOK)
www.streetinsider.com - July 31 at 9:20 AM
4-traders.com logoEvoke Pharma : Announces $10 Million Registered Direct Offering Priced At-The-Market (NASDAQ:EVOK)
www.4-traders.com - July 31 at 9:20 AM

Social

Evoke Pharma (NASDAQ:EVOK) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff